Huron Consulting (HUR) Q2 2026 Earnings Report
DE:HUR Q2 2026 EPS Results
- Actual EPS
- EUR 2.20
- Consensus EPS
- EUR 1.95
- Beat/Miss
- Beat by +EUR 0.26
- One Year Ago EPS
- EUR 1.69
DE:HUR Q2 2026 Revenue Results
- Actual Revenue
- EUR 425.35M
- Expected Revenue
- EUR 402.01M
- Beat/Miss
- Beat by +EUR 23.34M
- YoY Revenue Growth
- +15.37%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/28/2026
- Time
- After Close
- Conference Call
- Tuesday, July 28, 2026
Huron Consulting's next earnings date is estimated for November 3, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
The call conveyed strong positive operational and financial momentum: record RBR, robust organic growth, significant adjusted EPS growth (+30% adjusted EPS YoY), margin expansion, strong free cash flow, raised guidance, and accelerating AI-driven digital bookings and managed services. Areas of caution include higher unallocated corporate expenses, a less favorable effective tax rate, leverage that remains above the target range (though improving), and near-term capacity/hiring needs driven by elevated utilization. On balance the positives materially outweigh the challenges.
Huron raised and narrowed full-year RBR guidance to $1.85B–$1.89B (≈+12% at the midpoint vs. 2025), maintained adjusted EBITDA margin guidance of 14.5%–15.0% of RBR (≈+50 bps vs. 2025 midpoint) and increased adjusted non‑GAAP EPS to $9.00–$9.40 (≈+17% at the midpoint vs. 2025); free cash flow is expected to be $180M–$220M (net of cash taxes and interest, excl. noncash stock comp) with free cash flow per share at about $12 at the midpoint (≈10% yield at a $120 share price). Management expects RelateCare to add ~$30M of 2026 RBR and be ~+$0.10 accretive to 2026 adjusted EPS, and reiterated segment targets of Healthcare RBR mid‑teen growth with ~30%–32% operating margins, Education RBR mid‑ to upper‑single‑digit growth with 24%–26% margins, and Commercial RBR low‑teen growth with 19%–21% margins; unallocated corporate expenses (ex. restructuring and deferred comp) are expected to rise low‑double‑digits vs. 2025, full‑year diluted shares are guided to ~16.6–16.8M, and the company reiterated its leverage target of 2.0x–2.5x by year‑end (vs. 2.8x adj. EBITDA as of 6/30/26).
- Record RBR and Revenue GrowthRecord revenues before reimbursable expenses (RBR) of $465.6M in Q2 2026, up 15.7% year-over-year (from $402.5M) with 10.8% organic RBR growth in the quarter.
- Raised Full-Year GuidanceUpdated full-year RBR guidance increased and narrowed to $1.85B–$1.89B, representing ~12% growth at the midpoint versus 2025; adjusted non-GAAP EPS guidance increased to $9.00–$9.40, ~17% growth at the midpoint.
- Margin Expansion and ProfitabilityAdjusted EBITDA of $72.6M in Q2 2026 (15.6% of RBR) vs $60.6M (15.1% of RBR) in Q2 2025, reflecting continued margin expansion; adjusted net income (adjusted EPS) of $40.2M or $2.46 per diluted share, up 30.2% year-over-year.
- Strong Net Income and EPSGAAP net income of $31.2M or $1.91 per diluted share in Q2 2026 versus $19.4M or $1.09 in Q2 2025; net income margin increased to 6.6% from 4.7%.
- Robust Free Cash Flow and Cash From OpsOperating cash flow of $120.5M and free cash flow of $111.3M in Q2 2026 versus operating cash flow of $80.1M in prior-year quarter; full-year free cash flow guidance $180M–$220M, midpoint implying ~ $12 free cash flow per share.
- Bookings and Digital MomentumFirst-half digital bookings increased >20% year-over-year; digital capability RBR grew 9% in Q2 2026 (year-over-year and sequential); >60% of digital bookings in H1 2026 included direct AI scope or AI-enabled delivery (up from ~35% in H1 2025).
- Managed Services AccelerationHealthcare managed services RBR grew 64% in Q2 2026 vs Q2 2025, including 43% organic growth; strong client retention and outcomes-based pricing driving recurring revenue and higher margins.
- Segment Performance — Healthcare, Education, CommercialHealthcare RBR $232.3M, up 17.4% YoY (50% of company RBR); Education RBR $139.4M, up 7.8% YoY (30% of company RBR) with operating margin improvement to 26.8% from 25%; Commercial RBR $94.0M, up 24.6% YoY (12.2% organic excluding acquisitions) with operating margin improvement to 21% from 16.6%.
- Accretive M&A and Strategic AdditionsAcquisition of RelateCare expected to add ~ $30M of RBR in 2026 and be accretive to 2026 adjusted EPS by approximately $0.10; acquisitions also contributed incremental RBR in the quarter from Treliant, Wilson Perumal, Eclipse Insights and Axiom.
- Capital Allocation and Share RepurchasesQ2 2026 share repurchases of ~$53.1M (~438k shares); YTD repurchases ~$208.6M (~1.6M shares, ~9% of outstanding shares at the start of the year); net debt decreased sequentially and leverage improved to 2.8x adjusted EBITDA from 3.1x at Q1.
DE:HUR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 03, 2026 | 2026 (Q3) | 2.22- | 1.88 | ― | ― |
| Jul 28, 2026 | 2026 (Q2) | 1.952.20 | 1.69 | 30.16% (+0.51) | |
| May 05, 2026 | 2026 (Q1) | 1.431.55 | 1.5 | 2.98% (+0.04) | |
| Feb 24, 2026 | 2025 (Q4) | 1.751.94 | 1.7 | 14.21% (+0.24) | |
| Oct 28, 2025 | 2025 (Q3) | 1.771.88 | 1.5 | 25.00% (+0.38) | |
| Jul 31, 2025 | 2025 (Q2) | 1.611.69 | 1.5 | 12.50% (+0.19) | |
| Apr 29, 2025 | 2025 (Q1) | 1.041.50 | 1.1 | 36.59% (+0.40) | |
| Feb 25, 2025 | 2024 (Q4) | 1.361.70 | 1.16 | 47.29% (+0.55) | |
| Oct 29, 2024 | 2024 (Q3) | 1.441.50 | 1.24 | 20.86% (+0.26) | |
| Jul 30, 2024 | 2024 (Q2) | 1.381.50 | 1.24 | 21.74% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

